Visceral Aneurysm Formation and Intraabdominal Hemorrhage Associated with Immune Checkpoint Inhibitor Therapy

J Vasc Interv Radiol. 2021 Jan;32(1):151-152. doi: 10.1016/j.jvir.2020.08.003. Epub 2020 Dec 2.

Authors

Andrew Y Lee¹, Alexander Lam¹, Robert M Hicks¹, Masis Isikbay¹, Michael B Heller¹, Mark D Sugi¹, Spencer Behr¹, Maureen P Kohi¹

Affiliation

¹ Department of Radiology and Biomedical Imaging, University of California, San Francisco, 505 Parnassus Ave., Suite M-361, San Francisco, CA 94143.

PMID: 33277167
DOI: 10.1016/j.jvir.2020.08.003

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aneurysm / chemically induced*
Aneurysm / diagnostic imaging
Aneurysm / therapy
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Embolization, Therapeutic
Female
Hemoperitoneum / chemically induced*
Hemoperitoneum / diagnostic imaging
Hemoperitoneum / therapy
Hemorrhage / chemically induced*
Hemorrhage / diagnostic imaging
Hemorrhage / therapy
Humans
Immune Checkpoint Inhibitors / adverse effects*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Immune Checkpoint Inhibitors
pembrolizumab